Search earnings tickers

TMO

2026Q2BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2026-07-23 · Fiscal end 2026-06-30 · Features as of 2026-07-22

← Earnings history

Street

Consensus EPS5.71

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.1%

IV front—

P/C full—

P/C front—

Features as of2026-07-22

Run-up

Close—

Ret 5d-1.6%

Ret 10d+3.2%

Ret 20d+12.2%

Ret 30d+12.1%

Print

Actual EPS

6.03Beat

Estimated EPS5.71

Actual revenue

12.0B

Surprise %+5.6%

Beat / missBeat

Beat streak 44

Beat streak 88

Reaction

1-day stock reaction-0.2%

Implied vs actual

Implied 2.1%Actual 9.0%

Gap reaction+9.0%

Day result+8.7%

Next-day upNo

Realized / IV4.18×

Post tape

Post 5d+0.8%

Post 10d+1.3%

Post volume5.8M

Vol ×10d3.09×

Vol ×20d2.71×

Post range3.3%

TMO

Pre-Earnings Data